{"id":7295,"date":"2025-11-07T12:15:45","date_gmt":"2025-11-07T11:15:45","guid":{"rendered":"https:\/\/www.commeo-law.com\/?p=7295"},"modified":"2025-11-07T12:15:45","modified_gmt":"2025-11-07T11:15:45","slug":"the-teva-copaxone-decision-drawing-the-line-between-pharma-ip-rights-and-antitrust-law","status":"publish","type":"post","link":"https:\/\/www.commeo-law.com\/en\/the-teva-copaxone-decision-drawing-the-line-between-pharma-ip-rights-and-antitrust-law\/","title":{"rendered":"The Teva Copaxone Decision: Drawing the Line Between Pharma, IP Rights and Antitrust Law"},"content":{"rendered":"<p>A focused look at how the European Commission\u2019s EUR 462.6 million Teva decision reshapes the concept of competition on the merits in pharma antitrust enforcement<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A focused look at how the European Commission\u2019s EUR 462.6 million Teva decision reshapes the concept of competition on the merits in pharma antitrust enforcement<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[21],"tags":[],"class_list":["post-7295","post","type-post","status-publish","format-standard","hentry","category-newsletter-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.commeo-law.com\/en\/wp-json\/wp\/v2\/posts\/7295","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.commeo-law.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.commeo-law.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.commeo-law.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.commeo-law.com\/en\/wp-json\/wp\/v2\/comments?post=7295"}],"version-history":[{"count":3,"href":"https:\/\/www.commeo-law.com\/en\/wp-json\/wp\/v2\/posts\/7295\/revisions"}],"predecessor-version":[{"id":7300,"href":"https:\/\/www.commeo-law.com\/en\/wp-json\/wp\/v2\/posts\/7295\/revisions\/7300"}],"wp:attachment":[{"href":"https:\/\/www.commeo-law.com\/en\/wp-json\/wp\/v2\/media?parent=7295"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.commeo-law.com\/en\/wp-json\/wp\/v2\/categories?post=7295"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.commeo-law.com\/en\/wp-json\/wp\/v2\/tags?post=7295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}